Richard W Krasula

Title: Innovations by Richard W. Krasula in Medical Device Technology

Introduction

Richard W. Krasula is a notable inventor based in Libertyville, IL, whose work primarily focuses on advancements in medical device technologies. With a total of two patents to his name, Krasula's contributions have made significant strides in the delivery of therapeutic agents through innovative medical solutions.

Latest Patents

One of Richard W. Krasula's latest patents is centered on the delivery of highly lipophilic agents via medical devices. This patent describes an apparatus and system designed for delivering a lipophilic agent in conjunction with a medical device. The invention specifically highlights a medical device that uses a first lipophilic agent capable of penetrating a body lumen, with transfer coefficients that are statistically significant at an approximate value of 5,000. The device is strategically placed adjacent to the body lumen to ensure that a therapeutically effective amount of the lipophilic agent reaches the desired area within a subject. Additionally, the invention encompasses a method aimed at improving patency within a subject, involving the placement of a medical device in a body lumen for the treatment and prevention of adjacent diseases or to maintain the patency of the body lumen.

Career Highlights

Richard W. Krasula is currently affiliated with Abbott Laboratories Corporation, where he continues to innovate in the field of medical devices. His career is marked by a commitment to developing technologies that enhance patient care and improve treatment outcomes.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues such as Keith R. Cromack and John L. Toner. Together, they have contributed to advancements that reflect a dedication to improving medical device efficacy and safety.

Conclusion

In summary, Richard W. Krasula's work exemplifies the profound impact that innovative inventions can have in the field of medicine. His patents not only enhance our understanding of lipophilic agent delivery but also demonstrate the value of collaboration in achieving breakthroughs that benefit healthcare.